Art. 5 Decision_act (EU) 2010/381

In forcesince 8 Jul 2010cited 1×
1.

Member States shall immediately inform the Commission of the results of the analytical tests if those tests reveal the presence of residues of any pharmacologically active substance:

(a)

classified in accordance with Article 14(2)(a), (b) or (c) of Regulation (EC) No 470/2009 at a level exceeding the maximum residue limit established pursuant to that Regulation; or

(b)

not classified in accordance with Article 14(2)(a), (b) or (c) of Regulation (EC) No 470/2009; however, the Member State concerned is not required to immediately inform the Commission of the results of such tests where the level of residues is lower than:

(i)

the reference point for action established for that substance pursuant to Regulation (EC) No 470/2009; or

(ii)

the minimum required performance limit established for that substance pursuant to Decision 2002/657/EC.

The results of those analytical tests shall be notified to the Commission under the rapid alert system established pursuant to Article 50 of Regulation (EC) No 178/2002.

2.

Every three months Member States shall submit to the Commission a report on all the results of the analytical tests carried out on the consignments in the previous three months.

The first report shall be submitted to the Commission by 1 October 2010.

  • Decision_act (EU) 2016/1774Lawamends

    … от задължението за тримесечно докладване, предвидено в член 5, параграф 2 от Решение 2010/381/ЕС.